Tag Archives: ALDX

Oppenheimer Keeps a Buy Rating on Aldeyra Therapeutics (ALDX)

In a report released today, Justin Kim from Oppenheimer maintained a Buy rating on Aldeyra Therapeutics (ALDX – Research Report), with a price target of $15.00. The company’s shares closed last Thursday at $6.76. According to TipRanks.com, Kim is a

Laidlaw Keeps a Buy Rating on Aldeyra Therapeutics (ALDX)

Laidlaw analyst Yale Jen reiterated a Buy rating on Aldeyra Therapeutics (NASDAQ: ALDX) on May 7 and set a price target of $30.00. The company’s shares closed last Tuesday at $4.11. Aldeyra Therapeutics has an analyst consensus of Strong Buy,

Janney Montgomery Reiterates Buy on Aldeyra Therapeutics Shares, Sees 581% Upside For The Stock

In a research report issued on Friday, Janney Montgomery analyst Esther Hong reiterated a Buy rating on Aldeyra Therapeutics (NASDAQ:ALDX)with a price target of $28, which implies an upside of 581% from current levels. According to TipRanks.com, which measures analysts’

Aldeyra Therapeutics (ALDX) Receives a Buy from JonesTrading

JonesTrading analyst Matthew Cross reiterated a Buy rating on Aldeyra Therapeutics (ALDX – Research Report) today and set a price target of $34.00. The company’s shares closed last Monday at $2.59, close to its 52-week low of $2.50. According to

JonesTrading Sticks to Its Buy Rating for Aldeyra Therapeutics (ALDX)

In a report released today, Matthew Cross from JonesTrading maintained a Buy rating on Aldeyra Therapeutics (ALDX – Research Report), with a price target of $34.00. The company’s shares closed last Monday at $4.84, close to its 52-week low of

Aldeyra Therapeutics (ALDX) Gets a Buy Rating from JonesTrading

JonesTrading analyst Matthew Cross maintained a Buy rating on Aldeyra Therapeutics (ALDX – Research Report) today and set a price target of $34.00. The company’s shares closed last Monday at $5.53, close to its 52-week low of $4.31. According to